Suzetrigine

JOURNAVX (suzetrigine) is a prescription oral tablet made by Vertex Pharmaceuticals, containing 50 mg of the active ingredient. It works as a sodium channel blocker and affects certain liver enzymes. Approved for marketing starting January 30, 2025. This information was generated using AI and is provided for informational and research purposes only.